Additional information
| Active substance | Metformin, Pioglitazone |
|---|---|
| Water Retention | Moderate (Pioglitazone) |
| Hepatotoxicity | Low risk, but monitoring is advised |
| Lab Test | Monitoring of liver function tests, kidney function tests, and blood glucose levels |
| Strength | 15/500mg |
| Also known as | Pioglitazone/Metformin combination |
| Blood pressure | Can potentially lower blood pressure |
| Trade name | Actoplus Met |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | Pioglitazone Hydrochloride, Metformin Hydrochloride |
| Formula | Pioglitazone: C19H20N2O3S В· HCl |
| Substance class | Thiazolidinedione (Pioglitazone), Biguanide (Metformin) |
| Main action | Antidiabetic |
| Half-life | Pioglitazone: 3-7 hours |
| Dosage (medical) | Typically 15-30 mg of Pioglitazone combined with 500-2000 mg of Metformin daily |
| Dosage (sports) | Not applicable |
| Effects | Reduces insulin resistance, decreases glucose production in the liver |
| Side effects | Weight gain, edema, risk of heart failure (Pioglitazone), gastrointestinal disturbances, lactic acidosis (Metformin) |
| Use in sports | Not typically used |
| Manufacturer | USV Pvt. Ltd. |
| Packing | 10 tabs/blister |
Avory Pharma Deca Durabolin 300mg 10ml
Aldactone Ali Raif Pharma (ARIS)
Norvacs 10 mg Pfizer
Benelux Pharma Decanoat. 250mg 10ml
Avory Pharma Testosteron Depot 300mg 10ml
Alpha Pharma Boldebolin 250 mg 10 Ampere
Champix 56 tabs Pfizer
Tavanic 500 mg Sanofi 




Reviews
There are no reviews yet.